The main objective of this multicenter cohort study is to determine the degree of COVID19 infection immunization of a population of psychiatric patients. The secondary objective of this cohort follow-up is to: 1. Clinically characterize COVID patients who are positive for serological testing 2. Assess the socio-demographic, clinical and psychotropic determinants of a COVID diagnosis 3. Immunologically characterize COVID patients who are positive for serological testing 4. Exploring the links between susceptibility to COVID19 and erythrocytic blood groups
All patients accepting to participate will be included in participating psychiatry services and will have a COVID Serological Test for Inclusion with confirmation at J15 including immune-genetics data. A Comparison of COVID patients versus no COVID patients will be based on a clinical examination (psychiatric, somatic) and blood samples collected at J0 and J15.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
200
serological COVID19 test with confirmation at J15 during hospitalization
Assistance Publique - Hôpitaux de Paris
Paris, Île-de-France Region, France
RECRUITINGNumber of COVID-positive patients
Number of COVID-positive patients, defined by a positive serological test result by immuno-chromatography at inclusion or at 15 days.
Time frame: day 15
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.